EUCTR2006-005942-35-IT进行中（未招募）不适用
Simvastatin therapy in IBM - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2007年6月4日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •IBM patient, males/females, age beetwen 18 and 75 years, patients able to give informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •patient with severe form of IBM, with hight risk of developing muscolar toxicity
研究者
相似试验
招募中
2 期
Effect of simvastatin in treatment of pachyonychia congenitaIRCT20160320027109N3Shahid Beheshti University of Medical Sciences20
已完成
不适用
Simvastatin treatment inhibit monocyte chemotactic protein-1 (MCP-1) gene in endometriosisendometriosisMCPǃImmune responseEndometriosisTCTR20130627003Ramathibodi hospital20
进行中（未招募）
不适用
Simvastatin treatment in inclusion body myositis (IBM) - NDEUCTR2007-004359-12-ITISTITUTO NEUROLOGICO CARLO BESTA
招募中
不适用
Effect if Simvastatin (Drug) in Liver CirrhosisCTRI/2021/12/038917Institute of Liver and Biliary Sciences
尚未招募
不适用
Effects of Usage of Simvastatin in Mild to Moderate Traumatic Brain Injury (TBI) Patients. Could it Make a Difference?Traumatic Brain InjuryNCT05551871Assiut University60